BEAM
Price
$19.87
Change
+$0.74 (+3.87%)
Updated
Apr 23 closing price
Capitalization
1.92B
19 days until earnings call
PLUR
Price
$6.75
Change
+$1.95 (+40.62%)
Updated
Apr 23, 04:59 PM (EDT)
Capitalization
33.59M
Ad is loading...

BEAM vs PLUR

Header iconBEAM vs PLUR Comparison
Open Charts BEAM vs PLURBanner chart's image
Beam Therapeutics
Price$19.87
Change+$0.74 (+3.87%)
Volume$2.13M
Capitalization1.92B
Pluri
Price$6.75
Change+$1.95 (+40.62%)
Volume$200
Capitalization33.59M
BEAM vs PLUR Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. PLUR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and PLUR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BEAM: $19.87 vs. PLUR: $6.76)
Brand notoriety: BEAM and PLUR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 84% vs. PLUR: 1828%
Market capitalization -- BEAM: $1.92B vs. PLUR: $33.59M
BEAM [@Biotechnology] is valued at $1.92B. PLUR’s [@Biotechnology] market capitalization is $33.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whilePLUR’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • PLUR’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and PLUR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish.

  • BEAM’s TA Score: 4 bullish, 5 bearish.

Price Growth

BEAM (@Biotechnology) experienced а +19.55% price change this week, while PLUR (@Biotechnology) price change was +86.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

PLUR is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.92B) has a higher market cap than PLUR($33.6M). PLUR YTD gains are higher at: 12.281 vs. BEAM (-19.879). PLUR has higher annual earnings (EBITDA): -19.28M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. PLUR (21.3M). PLUR has less debt than BEAM: PLUR (29.3M) vs BEAM (161M). BEAM has higher revenues than PLUR: BEAM (63.5M) vs PLUR (678K).
BEAMPLURBEAM / PLUR
Capitalization1.92B33.6M5,726%
EBITDA-383.98M-19.28M1,992%
Gain YTD-19.87912.281-162%
P/E RatioN/AN/A-
Revenue63.5M678K9,366%
Total Cash851M21.3M3,995%
Total Debt161M29.3M549%
FUNDAMENTALS RATINGS
PLUR: Fundamental Ratings
PLUR
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
70
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 20 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEYAX32.88N/A
N/A
Putnam Large Cap Value A
DNDGX16.51N/A
N/A
Dunham Small Cap Growth N
ALVDX9.92N/A
N/A
American Century Focused Lg Cap Val R6
DHANX13.81N/A
N/A
Centre American Select Equity Investor
LYRBX24.16N/A
N/A
Lyrical US Value Equity Investor

PLUR and

Correlation & Price change

A.I.dvisor tells us that PLUR and KOD have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLUR and KOD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLUR
1D Price
Change %
PLUR100%
+10.60%
KOD - PLUR
29%
Poorly correlated
+12.00%
CSBR - PLUR
25%
Poorly correlated
-0.76%
ORIC - PLUR
24%
Poorly correlated
+7.19%
BEAM - PLUR
24%
Poorly correlated
+4.88%
DMAC - PLUR
24%
Poorly correlated
+9.92%
More